Yunbo Yuling Wei

Dr. Yunbo Yuling Wei


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2022 in Carbohydrate Polymers
Verified
Journal Article
Closed access
YSYingying Song
Yingying Song
XQXinyan Qu
Xinyan Qu
MGMei Guo
Mei Guo
Qiongzheng HuQiongzheng Hu
Qiongzheng Hu
YMYan Mu
Yan Mu
CMCharles R. Mackay
Charles R. Mackay

25 September 2020 in Oncology Reports
Verified
Journal Article
Closed access
PDF file
JFJinhong Feng
Jinhong Feng
TZTing Zheng
Ting Zheng
ZHZhaohua Hou
Zhaohua Hou
CLCui Lv
Cui Lv
AXAnqi Xue
Anqi Xue
YWYunbo Yuling Wei
Yunbo Yuling Wei
Estrogen receptor (ER)‑negative breast tumors are associated with low survival rates, which is related to their ability to grow and metastasize into distal organs. The aryl hydrocarbon receptor (AhR), a ligand‑activated transcription factor that is involved in several biological processes, is a promising anti‑metastatic target. Luteolin, a non‑toxic naturally occurring plant flavonoid with diverse biological activities, has been demonstrated to be effective against certain types of cancer, and has also been described as a ligand of AhR. In the present study, various cancer cell lines were first investigated following treatment with luteolin, and luteolin exhibited the lowest IC50 in MDA‑MB‑231 cells. Then, the efficiency of luteolin in suppressing the metastasis of ER‑negative breast cancer in vitro was assessed. MDA‑MB‑231 cells were treated with luteolin in vitro. Subsequently, MTT assay and flow cytometry were used to detect cell viability, the cell cycle and apoptosis, and a Transwell assay was used to evaluate cell invasion. In addition, reverse transcription‑semi‑quantitative PCR and western blot were performed to detect the mRNA and protein expression levels of matrix metalloproteinase (MMP)‑2 and MMP‑9. In addition, the number of surface tumor nodules was measured in vivo, in mice bearing B16‑F10 tumors, following treatment with luteolin. Luteolin inhibited the viability and induced the apoptosis of MDA‑MB‑231 cells, which was accompanied by cell cycle arrest. This was associated with a decrease in the expression of the pro‑metastatic markers C‑X‑C chemokine receptor type 4 (CXCR4), MMP‑2 and MMP‑9, which was reversed by AhR inhibition. Furthermore, it was identified that luteolin could inhibit the metastasis in a B16F10 mouse xenograft model, and the levels of MMP‑9, MMP‑2 and CXCR4 were significantly decreased in the lung tissues isolated from tumor‑bearing nude mice following luteolin treatment. In conclusion, luteolin is a potential molecule for inhibiting breast cancer invasion and metastasis, which could have promising clinical applications.

4 March 2026 in Nature
Verified
Journal Article
Closed access
PDF file
NWNaiqi Wang
Naiqi Wang
ZCZhian Chen
Zhian Chen
YYYin Yao
Yin Yao
Chenglong SunChenglong Sun
Chenglong Sun
WWWei Wei
Wei Wei
DYDi Yu
Di Yu

Verified
Journal Article
Open access
PDF file
QXQi Xu
Qi Xu
MGMei Guo
Mei Guo
HWHaidi Wang
Haidi Wang
HLHaitao Liu
Haitao Liu
YWYunbo Yuling Wei
Yunbo Yuling Wei
QWQuanbo Wang
Quanbo Wang
Alcoholic liver disease (ALD) is a globally prevalent form of liver disease for which there is no effective treatment. Recent studies have found that a significant decrease in butyrate was closely associated with ALD development. Given the low compliance and delivery efficiency associated with oral-route butyrate administration, a highly effective butyrate-yielding dietary supplement, butyrylated high-amylose maize starch (HAMSB), is a good alternative approach. Here, we synthesized HAMSB, evaluated the effect of HAMSB on acute ALD in mice, compared its effect with that of oral administration of butyrate, and further studied the potential mechanism of action. The results showed HAMSB alleviated acute ALD in mice, as evidenced by the inhibition of hepatic-function impairment and the improvement in liver steatosis and lipid metabolism; in these respects, HAMSB supplementation was superior to oral sodium butyrate administration. These improvements can be attributed to the reduction of oxidative stress though the regulation of Nrf2-mediated antioxidant signaling in the liver and the improvement in the composition and function of microbiota in the intestine. In conclusion, HAMSB is a safe and effective dietary supplement for preventing acute ALD that could be useful as a disease-modifying functional food or candidate medicine.

11 January 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
WRWenjing Ren
Wenjing Ren
HZHuiru Zhu
Huiru Zhu
DSDongshuai Shang
Dongshuai Shang
XZXinyu Zhou
Xinyu Zhou
HZHua Zhang
Hua Zhang
PSPing Sun
Ping Sun

17 April 2026 in Nature Computational Science
Verified
Journal Article
Closed access
PDF file
YYYang Yang
Yang Yang
JGJialei Gong
Jialei Gong
HSHongjian Sun
Hongjian Sun
ACAmos Choo
Amos Choo
JMJessica Cara Mar
Jessica Cara Mar
DYDi Yu
Di Yu